May 2 (Reuters) - Moderna (MRNA.O), opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC) advisers to recommend the company's respiratory syncytial virus (RSV) ...

US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky signed off on a recommendation of Moderna's Covid-19 vaccine for people ages 6 to 17, the agency announced Friday. The move ...

(Reuters) -Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control and ...

The Africa CDC responded to Moderna’s plans to step back from building a mRNA vaccine manufacturing facility in Kenya, saying the move by the Spikevax maker only "perpetuates" the inadequate response ...

SAN FRANCISCO -- Moderna announced people may need a second booster to increase protection. But is a fourth shot the right approach? ABC7 News reporter Luz Pena from San Francisco spoke to multiple ...

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange ...

The Centers for Disease Control and Prevention on Tuesday recommended that all Americans ages 6 months and older receive updated Covid shots from Pfizer and Moderna. CDC Director Mandy Cohen signed ...

The CDC said 10 cases of confirmed anaphylaxis have occurred in patients shortly after receiving a Moderna COVID-19 vaccine, an average of 2.5 cases of anaphylaxis out of 1 million shots given. The ...